Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01728116 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese
A NA study, sponsored by Morphic Medical.
- Terminated
- Registry status
- NA
- Development phase
- 325
- Enrollment target
NCT01728116: Clinical Trial NA study, sponsored by Morphic Medical.
NCT01728116 is a NA study that was terminated before completion, run by Morphic Medical. The registered enrollment target is 325 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01728116, a NA study, was terminated before completion, sponsored by Morphic Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
Study Summary
To determine if the EndoBarrier safely and effectively improves glycemic control in obese subjects with type 2 diabetes
Primary Outcome
Mean Change in HbA1c from Baseline to 12 Months in the mITT population with Bayesian Imputation
Interventions
- PROCEDURE Sham Procedure
- DEVICE EndoBarrier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2012-12 |
| Est. Completion | 2016-02 |
| Phase | NA |
Why NCT01728116 stopped before completion
NCT01728116 is an interventional study that assigns participants to a tested intervention. The registered 325 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham Procedure is the first listed.
NCT01728116 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01728116 about?
NCT01728116 is a clinical study titled "Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese". To determine if the EndoBarrier safely and effectively improves glycemic control in obese subjects with type 2 diabetes
What is the current status of trial NCT01728116?
This trial is currently terminated. It is a NA study. The enrollment target is 325 participants. The study started on 2012-12. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01728116?
The interventions under investigation include: Sham Procedure (PROCEDURE), EndoBarrier (DEVICE).
Who is sponsoring clinical trial NCT01728116?
This trial is sponsored by Morphic Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01728116's enrollment target sits among peer trials
325 311th of 2000 higher than 1,689 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02543983 · 325 participants · Phase 2
Neurobiology of Suicide
- NCT03016819 · 325 participants · Phase 3
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
- NCT03288207 · 325 participants · NA
Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
- NCT04986657 · 325 participants · NA
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia